Pfizer’s CEO Albert Bourla and top management team held a planning meeting at Donald Trump’s Mar-a-Lago resort, seeking to build rapport with the president-elect. The move comes amid concerns over the appointment of vaccine skeptic Robert F Kennedy Jr to lead US health agencies. Bourla is among several corporate executives aiming to establish a direct relationship with Trump before his inauguration, with hopes of influencing policy on issues such as drug pricing and healthcare reform.
Full Article
Want to Avoid the "Magnificent Seven" and Generate Passive Income? This Vanguard ETF May Be for You
The "Magnificent Seven" stocks—Apple, Microsoft, Nvidia, Amazon, Alphabet, Meta Platforms, and Tesla—experienced significant gains in 2023 and 2024 but are now underperforming the S&P 500 in 2025, with Microsoft down 8.1% and Tesla over 35%. Investors seeking alternatives might consider the Vanguard High Dividend Yield ETF, which offers exposure to industry-leading companies across non-tech sectors, achieving a 2.9% dividend yield and a balanced sector allocation. This ETF, with a low expense ratio of 0.06%, is...
Read more